Kaiser Permanente Orange County-Irvine Medical Center — Irvine, California

Kaiser Permanente Orange County-Irvine Medical Center is a clinical research site located in Irvine, California, United States 92618.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Kaiser Permanente Orange County-Irvine Medical Center has participated in 2 clinical trials.

Therapeutic areas: Pelvic Organ Prolapse, Chronic Sinusitis, Nasal Polyposis.

Sponsors: University of California, Irvine, Intersect ENT.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Irvine

Browse all research sites in California · View every site in Irvine

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente Orange County-Irvine Medical Center?

Kaiser Permanente Orange County-Irvine Medical Center has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente Orange County-Irvine Medical Center conducted?

Kaiser Permanente Orange County-Irvine Medical Center has 2 clinical trials on record. Their work covers Pelvic Organ Prolapse, Chronic Sinusitis, Nasal Polyposis.

Is Kaiser Permanente Orange County-Irvine Medical Center accredited by Crixeo Clinical Trials?

Kaiser Permanente Orange County-Irvine Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kaiser Permanente Orange County-Irvine Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.